Launched with a quiet fanfare


Posted on May 1st, by editor in Journal of Dementia Care. No Comments

Excitement was kept under firm control at the launch of the first UK drug for Alzheimer’s disease. For a lucky few it is certainly beneficial, but as potential demand is so huge, financial and ethical issues must be faced. Robert Short describes the effects and efficacy of donepezil (Aricept).
Author/s: Robert Short
Vol: 5, Issue: 3, pp12





Comments are closed.


Latest blog posts

A weary sense of deja vu

By Caring Times editor GEOFF HODGSON

So we are to be favoured with a Green Paper sometime next summer.

Theresa May’s insistence on the importance of an...

It’s a hard, hard world

By Caring Times editor GEOFF HODGSON

A recent survey has found that 63% of the general public believe the NHS provides social care and 42% think...

Sign-up and pay, or perhaps pay more

By Caring Times editor GEOFF HODGSON

There are powerful arguments why carers working at night in small specialist care facilities should be paid their full hourly...